Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 10.98 is in line with its 5-year average of 11.32, near the low end of its 5-year range (0.16–55.08).
As of the fiscal period ended Tuesday, June 30, 2026. 8.85% below its 12-month average of 12.04.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.98.
CURRENT RATIO
10.98
CURRENT RATIO AVG TTM
12.04
CURRENT RATIO AVG 3Y
10.96
CURRENT RATIO AVG 5Y
11.32
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.85%
CURRENT VS 3Y AVG
+0.13%
CURRENT VS 5Y AVG
-3.02%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 630 covered companies
CURRENT VS SECTOR MEDIAN
+227.20%
vs the sector median at left
Kalaris Therapeutics Inc
Market Cap
$63.30M
Current Ratio
10.98
TTM Avg
12.04
3Y Avg
10.96
5Y Avg
11.32
Market Cap
$61.79M
Current Ratio
0.57
TTM Avg
2.81
3Y Avg
4.44
5Y Avg
7.47
Market Cap
$64.71M
Current Ratio
2.49
TTM Avg
2.38
3Y Avg
2.41
5Y Avg
2.71
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kalaris Therapeutics Inc (KLRS) | $63.30M | 10.98 | 12.04 | 10.96 | 11.32 |
| Alps Group Inc (ALPS)vs › | $63.23M | 0.36 | 0.31 | 0.29 | 1.05 |
| PDS Biotechnology Corporation (PDSB)vs › | $61.79M | 0.57 | 2.81 | 4.44 | 7.47 |
| InterCure Ltd. (INCR)vs › | $64.68M | 1.48 | 1.60 | 1.69 | 1.84 |
| Gossamer Bio, Inc. (GOSS)vs › | $64.94M | 0.53 | 4.76 | 5.20 | 7.10 |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.71M | 2.49 | 2.38 | 2.41 | 2.71 |
| Cingulate Inc. (CING)vs › | $66.27M | 3.50 | 1.85 | 1.22 | 3.58 |
| Adicet Bio, Inc. (ACET)vs › | $60.30M | 6.71 | 8.38 | 9.61 | 10.03 |
| MiNK Therapeutics, Inc. (INKT)vs › | $60.53M | 1.23 | 0.89 | 0.93 | 1.06 |
| Fortress Biotech, Inc. (FBIO)vs › | $67.60M | 3.96 | 1.88 | 1.73 | 2.58 |
Current Ratio
10.98
Quick Ratio
10.98
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 10.98 |
| 2026-03-31 | 12.14 |
| 2025-12-31 | 12.23 |
| 2025-09-30 | 12.89 |
| 2025-06-30 | 11.98 |
| 2025-03-31 | 14.31 |
| 2024-12-31 | 22.63 |
| 2024-09-30 | 0.16 |
| 2024-06-30 | 55.08 |
| 2024-03-31 | 18.48 |
| 2023-12-31 | 0.85 |
| 2023-09-30 | 6.65 |
| 2023-06-30 | 8.28 |
| 2023-03-31 | 8.50 |
| 2022-12-31 | 9.99 |
| 2022-09-30 | 13.13 |
| 2022-06-30 | 8.18 |
| 2022-03-31 | 11.08 |
| 2021-12-31 | 6.69 |
| 2021-09-30 | 11.66 |
| 2021-06-30 | 15.26 |
| 2021-03-31 | 21.91 |
| 2020-12-31 | 29.39 |
| 2020-09-30 | 28.40 |
| 2020-06-30 | 12.03 |
| 2020-03-31 | 15.27 |
| 2019-12-31 | 13.98 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
